The latest report by IMARC Group, titled “Hepatitis Diagnostic Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global hepatitis diagnostic tests market size reached US$ 5.3 Billion in 2021. Hepatitis refers to the inflammation of the liver that can be contracted through viral infections. It can lead to liver cancer, cirrhosis, scarring, and fibrosis in the liver caused by alcohol, toxins, drugs, medication, and autoimmune hepatitis. Hepatitis diagnostic tests are performed to determine the genotype of hepatitis that is causing the disease by collecting blood samples to detect the antibody and antigen assays of the virus. These tests also play a vital role in the early detection of hepatitis A, B, or C infections and increasing the chances of survival of the patient by taking correct medication and treatment.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Hepatitis Diagnostic Tests Market Trends:
The global hepatitis diagnostic tests market is primarily driven by the growing burden of hepatitis. Besides this, the rising number of blood transfusions and donations has escalated the need for hepatitis diagnostic tests as the use of unsafe blood and blood components is a common way of transmitting the infection. In recent years, there has also been a shift from conventional technologies to molecular diagnostics for improving the competence of procedures and decreasing the dispatch time for results. Furthermore, the availability of advanced detection techniques, such as molecular diagnostics, helps confirm the exact strain of the virus with the help of genetic testing through nucleic acid assays and immunoassays. Moreover, various initiatives worldwide to create awareness among the masses regarding the commercially available advanced diagnostic products and the benefits offered by point of care (POC) instruments and kits are providing a positive outlook to the market. Looking forward, the market is expected to grow at a CAGR of 5.25% during the forecast period (2022-2027).
- Based on the test type, the market has been segmented into blood tests, imaging tests and liver biopsies. Blood tests currently represent the biggest application segment. Blood tests are further segregated into liver function tests, immunoassays, and nucleic acid tests. Amongst these, liver function tests currently represent the biggest segment.
- Region-wise, the market has been divided into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa. At present, North America is the biggest market, accounting for the majority of the global market.
- The competitive landscape of the market has been examined, with some of the key players being Siemens AG, Abbott Laboratories, MedMira Inc, Qiagen GmbH, Beckman Coulter Inc (Danaher Corporation), F. Hoffmann- La Roche AG, Diasorin S.p.A, bioMeriuex SA, Hologic Inc., and Bio-Rad Laboratories Inc.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Follow us on twitter: @imarcglobal